| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 111,906 | 49,412 | 29,879 | 137,819 | | Cost of Revenue | 64,119 | 30,671 | 21,793 | 89,678 | | | Gross Profit | 47,787 | 18,741 | 8,086 | 48,141 | | | Operating Expenses | | Research Development | 7,387 | 9,540 | 9,973 | 11,799 | | Selling General and Administrative | 28,844 | 24,793 | 22,106 | 71,214 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,486 | 2,638 | 2,899 | 3,843 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,070 | (18,230) | (26,892) | (38,715) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (756) | (166) | (254) | (3,819) | | Earnings Before Interest And Taxes | 8,314 | (18,396) | (27,146) | (42,534) | | Interest Expense | 3 | 2 | 25 | 315 | | Income Before Tax | 8,311 | (18,398) | (27,171) | (42,849) | | Income Tax Expense | 1,093 | (6,181) | (50) | 1,453 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,218 | (12,217) | (27,121) | (44,302) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,218 | (12,217) | (27,121) | (44,302) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,218 | ($12,217) | ($27,121) | ($44,302) |
|
0.01% Nasdaq 
Income Statement
